Rémy Bation1, Marine Mondino2, Florent Le Camus2, Mohamed Saoud3, Jerome Brunelin2. 1. INSERM U1028, CNRS UMR5292, PSYR2 Team, Lyon Neuroscience Research Center, Université Claude Bernard Lyon 1, Lyon, France; Centre Hospitalier Le Vinatier, Bron, France; Psychiatric Unit, Wertheimer Neurologic Hospital, CHU Lyon, F69500, Bron, France. Electronic address: remy.bation@chu-lyon.fr. 2. INSERM U1028, CNRS UMR5292, PSYR2 Team, Lyon Neuroscience Research Center, Université Claude Bernard Lyon 1, Lyon, France; Centre Hospitalier Le Vinatier, Bron, France. 3. INSERM U1028, CNRS UMR5292, PSYR2 Team, Lyon Neuroscience Research Center, Université Claude Bernard Lyon 1, Lyon, France; Centre Hospitalier Le Vinatier, Bron, France; Psychiatric Unit, Wertheimer Neurologic Hospital, CHU Lyon, F69500, Bron, France.
Abstract
BACKGROUND:Obsessive-compulsive disorder (OCD) is a severe mental disorder with poor response to the available treatments. Neuroimaging studies have identified dysfunctions within the orbito-fronto-striato-pallido-thalamic network in patients with OCD. Here, we assessed the efficacy and safety of transcranial direct current stimulation (tDCS) applied with the cathode over the orbitofrontal cortex (OFC) and the anode over the right cerebellum to decrease OCD symptoms in patients with treatment-resistant OCD. METHODS: In a randomized sham-controlled double-blind study, 21 patients with OCD were assigned to receive ten 20-min sessions (two sessions per day) of either active (2 mA) or sham tDCS. The clinical symptoms were measured using the Yale-Brown Obsessive and Compulsive Scale (YBOCS). Acute effects on the symptoms were measured from baseline to immediately after the 10 tDCS sessions. Long-lasting effects were measured 1 and 3 months after the 10th tDCS session. RESULTS: Compared with the sham tDCS, active tDCS significantly decreased OCD symptoms immediately after the 10th tDCS session (F(1,19) = 5.26, p = 0.03). However, no significant differences were observed between the active and sham groups in terms of changes in YBOCS score or the number of responders one and 3 months after tDCS. CONCLUSION: Despite significant acute effects, tDCS with the cathode placed over the left OFC and the anode placed over the right cerebellum was not significantly effective in inducing a long-lasting reduction of symptoms in patients with treatment-resistant OCD.
RCT Entities:
BACKGROUND:Obsessive-compulsive disorder (OCD) is a severe mental disorder with poor response to the available treatments. Neuroimaging studies have identified dysfunctions within the orbito-fronto-striato-pallido-thalamic network in patients with OCD. Here, we assessed the efficacy and safety of transcranial direct current stimulation (tDCS) applied with the cathode over the orbitofrontal cortex (OFC) and the anode over the right cerebellum to decrease OCD symptoms in patients with treatment-resistant OCD. METHODS: In a randomized sham-controlled double-blind study, 21 patients with OCD were assigned to receive ten 20-min sessions (two sessions per day) of either active (2 mA) or sham tDCS. The clinical symptoms were measured using the Yale-Brown Obsessive and Compulsive Scale (YBOCS). Acute effects on the symptoms were measured from baseline to immediately after the 10 tDCS sessions. Long-lasting effects were measured 1 and 3 months after the 10th tDCS session. RESULTS: Compared with the sham tDCS, active tDCS significantly decreased OCD symptoms immediately after the 10th tDCS session (F(1,19) = 5.26, p = 0.03). However, no significant differences were observed between the active and sham groups in terms of changes in YBOCS score or the number of responders one and 3 months after tDCS. CONCLUSION: Despite significant acute effects, tDCS with the cathode placed over the left OFC and the anode placed over the right cerebellum was not significantly effective in inducing a long-lasting reduction of symptoms in patients with treatment-resistant OCD.
Authors: Maximilian J Wessel; Chang-Hyun Park; Elena Beanato; Estelle A Cuttaz; Jan E Timmermann; Robert Schulz; Takuya Morishita; Philipp J Koch; Friedhelm C Hummel Journal: Sci Rep Date: 2021-01-19 Impact factor: 4.379
Authors: Jerome Brunelin; Marine Mondino; Julie Haesebaert; Jerome Attal; Michel Benoit; Marie Chupin; Sonia Dollfus; Wissam El-Hage; Filipe Galvao; Renaud Jardri; Pierre Michel Llorca; Laurent Magaud; Marion Plaze; Anne Marie Schott-Pethelaz; Marie-Françoise Suaud-Chagny; David Szekely; Eric Fakra; Emmanuel Poulet Journal: Trials Date: 2021-12-28 Impact factor: 2.279
Authors: Alexandra Kammen; Jonathon Cavaleri; Jordan Lam; Adam C Frank; Xenos Mason; Wooseong Choi; Marisa Penn; Kaevon Brasfield; Barbara Van Noppen; Stuart B Murray; Darrin Jason Lee Journal: Front Neurol Date: 2022-08-09 Impact factor: 4.086
Authors: Eduardo Cinosi; David Adam; Ibrahim Aslan; David Baldwin; Kieran Chillingsworth; Arun Enara; Tim Gale; Kabir Garg; Matthew Garner; Robert Gordon; Natalie Hall; Nathan T M Huneke; Sonay Kucukterzi-Ali; Joanne McCarthy; Daniel Meron; Deela Monji-Patel; Roisin Mooney; Trevor Robbins; Megan Smith; Nick Sireau; David Wellsted; Solange Wyatt; Naomi A Fineberg Journal: Pilot Feasibility Stud Date: 2021-12-06